Indication
Oncologic Disorders
Clinical trial
Prospective, Multicenter and Open Study to Evaluate the Efficacy of Esmolol in the Early Identification of Cardiovascular Disorders Induced by Cirrhosis, Diabetes Mellitus and Cardiotoxic TreatmentsStatus: Recruiting, Estimated PCD: 2027-03-01
Product
Esmolol